Tricuspid Valve Atresias, also known as Tricuspid Atresia, is a congenital heart defect characterized by the absence or severe narrowing of the tricuspid valve in the heart. The tricuspid valve is located between the right atrium and right ventricle and is responsible for regulating blood flow in the heart. In Tricuspid Valve Atresias, the valve fails to develop properly during fetal development, resulting in an abnormality.
Due to the absence or narrowing of the tricuspid valve, blood flow from the right atrium to the right ventricle is blocked or restricted. This condition leads to severe complications, as blood is unable to reach the lungs for oxygenation. Instead, blood from the right atrium is diverted to the left atrium through a hole in the wall separating the two chambers, such as an atrial septal defect or patent foramen ovale.
Symptoms of Tricuspid Valve Atresias include bluish skin discoloration (cyanosis), rapid breathing, poor feeding, fatigue, and stunted growth. Depending on the severity of the defect and associated anomalies, individuals with Tricuspid Valve Atresias may require immediate medical intervention, including surgical procedures to create a connection between the right atrium and right ventricle, restoring blood flow to the lungs.
Tricuspid Valve Atresias often requires long-term management and frequent medical follow-ups to ensure proper cardiac function. Treatment may involve medication, further surgical interventions, or heart transplantation if necessary. Early diagnosis and prompt medical intervention are crucial in managing the condition effectively and optimizing the individual's quality of life.
